Evidence map›Paper›PMID 35073248›Full record

ArticleAnnals of the American Thoracic Society2022

Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry.

Aparna C Swaminathan, Anne S Hellkamp, Megan L Neely, Shaun Bender, Luca Paoletti, Eric S White, Scott M Palmer, Timothy P M Whelan, Daniel F Dilling, Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry investigators

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Annals of the American Thoracic Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Health disparities and associated social determinants of health in interstitial lung disease: a narrative review.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  6. Article
  7. Observational
  8. Article
  9. Investigating the Impact of Social Determinants of Health on Diagnostic Delays and Access to Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Lung transplantation outcomes in patients from socioeconomically distressed communities.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Article
  18. Article
  19. Interstitial Lung Disease and Sarcoidosis.Clinics in chest medicine · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Aparna C SwaminathanDuke Clinical Research Institute, Durham, North Carolina.ORCID 0000-0002-0003-9971
Anne S HellkampDuke Clinical Research Institute, Durham, North Carolina.
Megan L NeelyDuke Clinical Research Institute, Durham, North Carolina.
Shaun BenderBoehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
Luca PaolettiDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; and.
Eric S WhiteBoehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
Scott M PalmerDuke Clinical Research Institute, Durham, North Carolina.
Timothy P M WhelanDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; and.
Daniel F DillingDivision of Pulmonary and Critical Care, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.ORCID 0000-0002-9723-510X
Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry investigators
Clinical Research Institute · USBoehringer Ingelheim (United States) · USMedical University of South Carolina · USLoyola University Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Idiopathic Pulmonary FibrosisLung TransplantationHumansProportional Hazards ModelsProspective StudiesRegistriesinterstitial lung diseaselung transplantationorgan transplantspulmonary fibrosis

Identifiers

PMID35073248
PMCPMC9169123
OpenAlexW4207070569

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.